Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice
S. S. LEE, V. G. BAIN, K. PELTEKIAN, M. KRAJDEN, E. M. YOSHIDA, M. DESCHENES, J. HEATHCOTE, R. J. BAILEY, S. SIMONYI, M. SHERMAN, THE CANADIAN PEGASYS STUDY GROUPVolume:
23
Year:
2006
Language:
english
DOI:
10.1111/j.1365-2036.2006.02748.x
File:
PDF, 217 KB
english, 2006